Clinical trial

Single Dose Radiotherapy (SDRT) With or Without Adjuvant Systemic Therapy for Oligometastatic Prostate Cancer

NCT04031378

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2019-09-01

PhasePHASE2

Study timeline

Study start (estimated)2019-09-01Date precision: day

Registry last updated2019-07-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metastatic Prostate Cancerunresolved

Prostate Adenocarcinomaunresolved

Interventions

Single Dose Radiotherapy (24 Gy) to all detectable lesions, followed by observationRADIATION

Single Dose Radiotherapy (24 Gy) to all detectable lesions followed by adjuvant systemic therapy for 6 monthsDRUG

Sponsors & collaborators

Fundacao Champalimaudlead sponsor

Mapped research locations

LisbonPortugal1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04031378 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.